FRANCISCO JOSE
HERMIDA PRADO
Investigador
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (9)
2023
-
Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics
Biomedicine and Pharmacotherapy, Vol. 158
-
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer
Cancer research, Vol. 83, Núm. 19, pp. 3284-3304
-
Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways
Biomedicine and Pharmacotherapy, Vol. 161
2021
-
Tumor-infiltrating cd20+ b lymphocytes: Significance and prognostic implications in oral cancer microenvironment
Cancers, Vol. 13, Núm. 3, pp. 1-16
2020
-
Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma
Oral Oncology, Vol. 110
-
Lectin-like transcript 1 (LLT1) checkpoint: A novel independent prognostic factor in HPV-negative oropharyngeal squamous cell carcinoma
Biomedicines, Vol. 8, Núm. 12, pp. 1-14
-
Prognostic significance of the pluripotency factors NANOG, SOX2, and OCT4 in head and neck squamous cell carcinomas
Cancers, Vol. 12, Núm. 7, pp. 1-15
2019
-
SOX2 expression is an independent predictor of oral cancer progression
Journal of Clinical Medicine, Vol. 8, Núm. 10
-
The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma
Cancers, Vol. 11, Núm. 11